Does precision medicine improve advanced cancer patient survival rates?

Written by Rachel Jenkins, Future Science Group

precision medicine

Researchers from the University of California San Diego School of Medicine (CA, USA) have demonstrated that patients receiving care for advanced cancer at Moores Cancer Center (CA, USA) are more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy. The study investigated a multidisciplinary tumor board to advise physicians on the course of care using an individual patient’s molecular tumor makeup to design precision medicine strategies. Razelle Kurzrock, lead investigator (Moores Cancer Center) commented: “Patients who underwent a molecular tumor board-recommended therapy were better matched to genomic alterations in their cancer...

To view this content, please register now for access

It's completely free